IMMUNOPHOTONICS INC
Saint Louis, MO · Founded 2008 · CIK 0001490953 · Biotech · Private
Proprietary glycan polymer that enhances antigen capture and immune activation
immunophotonics.com →- Grants
- $3.6M
- 4 awards
- Sector median: 1
- Raised
- $18M
- 6 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 18
- 3 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2009201120132015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $550,000 | |
| Private capital raised | Form D · SEC | $100,123 | |
| Private capital raised | Form D · SEC | $2,487,487 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation | $400,000 | |
| Private capital raised | Form D · SEC | $3,452,576 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation | $1,219,852 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation | $1,219,852 | |
| Private capital raised | Form D · SEC | $1,516,746 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation | $780,148 | |
| Private capital raised | Form D · SEC | $10,147,612 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1737 | EpimedX, LLC | — | — |
| 1738 | Alpha Cognition Inc. | — | $28M |
| 1739 | Opprtna Therapeutics, Inc. | — | $125K |
| 1740 | IMMUNOPHOTONICS INC | — | $18M |
| 1741 | Superluminal Medicines | — | $116M |
| 1742 | Gossamer Bio | — | $728M |
| 1743 | PHI OPTICS INC | — | $450K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Lu AlleruzzoExecutive Officer
- Luciano AlleruzzoDirector · Executive Officer · Promoter
- Shelly BishopDirector
- Charlie BoltenDirector
- Wei ChenDirector · Promoter
- Tomas HodeDirector · Executive Officer · Promoter
- Peter JenkinsDirector · Executive Officer
- Jonathan KnowlesDirector
- Robert NordquistDirector
- Bobby SandageDirector
- David SmollerDirector
- Miguel ZubizarretaDirector
Patents
- Chitosan-derived Compositionsgranted
- Glycated Chitosans For Treatment Of Viral Infectionsapplication
- Methods For Producing Glycated Chitosansapplication
- Chitosan-derived Compositionsgranted
- Semi-synthetic Biopolymers For Use In Stimulating The Immune Systemapplication
- Chitosan-Derived Compositionsgranted
- Semi-synthetic Biopolymers For Use In Treating Proliferative Disordersapplication
- Chitosan-Derived Compositionsapplication
- Chitosan-derived Compositionsapplication
- Chitosan-derived Compositionsapplication
- Compositions Of Chitosan And Modified Chitosansapplication
- Methods For Producing Glycated Chitosansapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.